Журнал включен в российские и международные библиотечные и реферативные базы данных
РИНЦ (Россия)
RINZ (RUSSIA)
Регистрационное агентство DOI (США)
DOI Registration Agency (USA)
Эко-Вектор (Россия)
Eco-Vector (Russia)
Ulrichsweb (Ulrich’s Periodicals Director

Prognostic value of myocardial remodeling in patients with arterial hypertension and coronary heart disease

DOI: https://doi.org/10.29296/25879979-2022-04-09
Download full text PDF
Issue: 
4
Year: 
2022

A. N. Kovalchuk, Branch №7 «1586 Military Clinical Hospital» of Ministry of Defense of Russia, Tver, Russian Federation, е-mail: [email protected].

Objective of the study. To study prognostic value of myocardial remodeling in patients with arterial hypertension and coronary heart disease according to the literature data. Material and Methods. 13 Russian and 3 foreign publications were analyzed, in which the prognostic value of myocardial remodeling in patients with arterial hypertension and coronary heart disease was discussed. Results. Left ventricular hypertrophy in patients with arterial hypertension is an independent risk factor of negative prognosis in patients with arterial hypertension. The detection of left ventricular dilatation was associated with a 98% increased risk of cardiovascular complications. Frequency of concentric hypertrophy, dilatation and diastolic dysfunction of the left ventricle was higher in those patients with atrial fibrillation than in the group without atrial fibrillation. Conclusion. Myocardial remodeling processes are associated with the progressing and worsening clinical course of arterial hypertension and coronary heart disease. Concentric hypertrophy and dilatation of the left ventricle are the most prognostically unfavorable variants of left ventricular structure and geometry disorders.
Keywords: 
myocardial remodelling
arterial hypertension
coronary heart disease
prognosis
nurse.

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Arterial hypertension in adults. Clinical guidelines 2020. Russian Journal of Cardiology. 2020;25(3):3786 (In Russ.) doi:10.15829/1560-4071-2020-3-3786
  2. Clinical practice guidelines for Stable coronary artery disease. Russian Journal of Cardiology. 2020;25(11):4076. (In Russ.) doi:10.15829/1560-4071- 2020-4076
  3. Clinical practice guidelines for Acute ST-segment elevation myocardial infarction. Russian Journal of Cardiology. 2020;25(11):4103. (In Russ.) doi:10.15829/1560-4071-2020-4103
  4. Usol`ceva O.N. Prevention of accelerated aging and «diseases of civilization» with natural geroprotectors BioChaga and BioDihydroquercetin. Medicinskaya sestra, 2022; (3): 34–40 https://doi.org/10.29296/25879979-2022-03-07 (In Russ.)
  5. Mamedov M.N., Kanorsky S.G. International clinical trials in cardiology (2010 – 2018). M.: Cardioprogress, 2019;122p. (In Russ.)
  6. Dedov D.V. Ivanov A.P., Elgardt I.A. Risk of recurrence of atrial fibrillation in patients with coronary heart disease and arterial hypertension according to Holter electrocardiogram monitoring. Bulletin of Arrhythmology. 2010; 59:27–32 (In Russ.)
  7. Fomina I.G., Dyakova T.A. Left ventricular hypertrophy in arterial hypertension and arrhythmia risk. Cardiovascular Therapy and Prevention. 2006;5(8):83–89. (In Russ.)
  8. Strutynsky A.V. Echocardiogram: analysis and interpretation. Moscow: MEDpress-inform, 2016:208p. (In Russ.)]
  9. Drapkina O.M., Dzhioeva O.N. Modern echocardiographic criteria for heart failure with preserved ejection fraction: not only diastolic dysfunction. Cardiovascular Therapy and Prevention. 2020;19(2):2454. (In Russ.) doi:10.15829/1728-8800-2020-2454
  10. Smirnova M.D., Ageev F.T. Left ventricular hypertrophy: prognostic value, pathogenesis, possible remodeling: focusing on angiotensin receptor antagonists. Cardiovascular Therapy and Prevention. 2007;6(6):109–116. (In Russ.)
  11. Kalyuzhin V.V., Teplyakov A.T., Solovtsov M.A. et al. Left ventricular remodeling: one or several scenarios? Bulletin of Siberian Medicine.2016;15(4):120–139. (In Russ.)
  12. Verdecchia P., Angeli F., Mazzotta G. et al. Impact of Chamber Dilatation on the Prognostic Value of Left Ventricular Geometry in Hypertension. J Am Heart Assoc. 2017;6(6):e005948. doi: 10.1161/JAHA.117.005948.
  13. Cuspidi C., Sala C., Tadic M. et al. High-normal blood pressure and abnormal left ventricular geometric patterns: a meta-analysis. J Hypertens. 2019;37(7):1312–1319. doi: 10.1097/HJH.0000000000002063.
  14. Dedov D.V., Ivanov A.P., Elgardt I.A. Effect of electromechanical remodeling of the heart on the development of atrial fibrillation in patients with CHD and arterial hypertension. Russian Journal of Cardiology. 2011;16(4):13–18. (In Russ.)
  15. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation. 1990;81(4):1161–72. doi: 10.1161/01.cir.81.4.1161.
  16. Dedov D., Mukailov N., Evtyukhin I. Combination of amlodipine and atorvastatin in reducing the risk of cardiovascular complications. Vrach 2013;3:18–19. (In Russ.)